Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1756-994X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics ; volume:6 ; number:12 ; day:12 ; month:12 ; year:2014 ; pages:1-10 ; date:10.2014
Genome medicine ; 6, Heft 12 (12.12.2014), 1-10, 10.2014

Creator: Guilhamon, Paul

Contributor: Butcher, Lee M.
Presneau, Nadege
Wilson, Gareth A.
Feber, Andrew
Paul, Dirk S.
Schütte, Moritz
Haybaeck, Johannes
Keilholz, Ulrich
Hoffman, Jens
Ross, Mark T.
Flanagan, Adrienne M.
Beck, Stephan
SpringerLink (Online service)

DOI: 10.1186/s13073-014-0116-0

URN: urn:nbn:de:1111-201604099212

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Guilhamon, Paul
Butcher, Lee M.
Presneau, Nadege
Wilson, Gareth A.
Feber, Andrew
Paul, Dirk S.
Schütte, Moritz
Haybaeck, Johannes
Keilholz, Ulrich
Hoffman, Jens
Ross, Mark T.
Flanagan, Adrienne M.
Beck, Stephan
SpringerLink (Online service)

Other Objects (12)

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts

Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Patient-derived xenografts as preclinical neuroblastoma models

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Molecular profiling of patient-derived breast cancer xenografts

Patient-derived xenografts as compatible models for precision oncology

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Patient-derived xenografts: a relevant preclinical model for drug development

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Hochschulschrift

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts

Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Patient-derived xenografts as preclinical neuroblastoma models

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Molecular profiling of patient-derived breast cancer xenografts

Patient-derived xenografts as compatible models for precision oncology

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Patient-derived xenografts: a relevant preclinical model for drug development

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Hochschulschrift

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts

Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Patient-derived xenografts as preclinical neuroblastoma models

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Molecular profiling of patient-derived breast cancer xenografts

Patient-derived xenografts as compatible models for precision oncology

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Patient-derived xenografts: a relevant preclinical model for drug development

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Hochschulschrift

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts

Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Patient-derived xenografts as preclinical neuroblastoma models

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Molecular profiling of patient-derived breast cancer xenografts

Patient-derived xenografts as compatible models for precision oncology

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Patient-derived xenografts: a relevant preclinical model for drug development

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts

Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Patient-derived xenografts as preclinical neuroblastoma models

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Molecular profiling of patient-derived breast cancer xenografts

Patient-derived xenografts as compatible models for precision oncology

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Patient-derived xenografts: a relevant preclinical model for drug development

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts

Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts

Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Patient-derived xenografts as preclinical neuroblastoma models

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Molecular profiling of patient-derived breast cancer xenografts

Patient-derived xenografts as compatible models for precision oncology

Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor

Patient-derived xenografts: a relevant preclinical model for drug development

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Oncolytic measles virus MV-NIS controls relapsed pediatric ALL patient-derived xenografts

Related objects

Reset password